Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,951,280
+$1,951,280 QoQ
Shares Held
195,128
Ownership
0.076%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#96
of 316 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 50%
Shared 50%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Derivatives in BCRX
reported options exposure · as of Jun 30, 2026CallValue
$899,000
CallShares
89,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TUDOR INVESTMENT CORP ET AL holds $64,629,641 across 19 Drug Manufacturers - Specialty & Generic names. BCRX ranks #7 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
490,000 | $16,601,200 | |
| 2 | ZTS |
Zoetis Inc.
|
208,246 | $14,964,557 | |
| 3 | HLN |
Haleon plc
|
762,877 | $7,117,642 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
12,667 | $6,863,360 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
256,108 | $6,302,817 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
128,796 | $4,465,357 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
195,128 | $1,951,280 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
100,149 | $1,605,388 |
All Filings in BCRX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,951,280 | 195,128 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $899,000 | 89,900 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $911,064 | 95,700 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $893,419 | 114,541 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $745,148 | 98,175 | Shares | Defined | 2025-12-09 | |
| 2025-06-30 | $1,604,592 | 179,084 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $787,815 | 105,042 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $747,864 | 99,450 | Shares | Defined | 2025-02-14 | |
| 2024-06-30 | $636,552 | 103,002 | Shares | Defined | 2024-08-14 | |
| 2023-12-31 | $1,257,330 | 209,905 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $668,599 | 94,435 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $539,700 | 76,662 | Shares | Defined | 2023-08-14 | |
| 2022-09-30 | $1,170,275 | 92,879 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $254,565 | 24,061 | Shares | Defined | 2022-08-15 | |
| 2021-09-30 | $1,883,418 | 131,066 | Shares | Defined | 2021-11-17 | |
| 2021-06-30 | $994,417 | 62,898 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $589,015 | 57,917 | Shares | Defined | 2021-05-17 | |
| 2020-03-31 | $98,204 | 49,102 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||